GoodRx Holdings (GDRX) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

GoodRx Holdings

NasdaqGS•Healthcare•Health Information Services

$3.39+0.04(0.01%)Pre-market

Market Cap

$1.15B

P/E

71.0x

P/S

1.5x

P/B

1.8x

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

How this company scores

AverageMetricSide Score: 51/100

Strongest: Cash & Earnings Quality (21/25); weakest: Growth (7/25).

Profitability9/25

Growth7/25

Balance Sheet & Red Flags14/25

Cash & Earnings Quality21/25

Strengths

Cash-backed earningsConsistent free cash flowImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 71.0x5y range 30.3x – 257.0x

Currently near its 9-quarter median.

P/S · 1.5x5y range 0.8x – 4.1x

Currently below its 20-quarter median.

P/B · 1.8x5y range 1.0x – 4.5x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 14.0% — watch for continued compression, which may signal competitive or cost pressure.

Revenue Decline

Watch

Revenue has softened, declining in 3 quarters. Watch for further erosion.

Price & Volume

Market Cap $1.15B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $785.23M
Q. Revenue: $200.41M
TTM EBITDA: $163.58M
TTM Op. Income: $74.94M
Q. Op. Income: $23.63M
TTM Net Income: $16.25M
Q. Net Income: $8.54M
EPS: $0.03
Shares Out.: $339.28M

$785.23M in TTM revenue declined 1.8% YoY, reaching $200.41M last quarter. TTM EBITDA of $163.58M and TTM operating income of $74.94M show growth is flowing through to the bottom line. TTM net income of $16.25M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 3 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 22.9%
Op. Margin: 11.8%
Net Margin: 4.3%

Op. margin of 11.8% is down 1.4% YoY — costs are rising relative to revenue. Net margin at 4.3% Over the past year, operating margin is down 11% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 71.0x
P/S Ratio: 1.5x
P/B Ratio: 1.8x

At 71.0x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 1.5x and P/B of 1.8x provide additional context. P/E sits above typical market levels while revenue growth is below 5%. Across the last 7 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.34B
Cash: $296.11M
Long-Term Debt: $481.59M
Book Value: $647.60M
D/E Ratio: 0.7
Debt/EBITDA: 10.5

With $2.34B in assets and $481.59M in long-term debt, D/E is 0.7and book value is $647.60M — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 3 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $80.83M
TTM Free Cash Flow: $197.09M
FCF Margin: 25.1%
FCF / Net Income: 12.1

TTM FCF of $197.09M on $80.83M in operating cash flow. The FCF / Net Income ratio of 12.1x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.